Kelly Turner faces conviction after abusing her daughter to death

A Colorado mother who pleaded guilty to abusing her 7-year-old daughter to death will be sentenced on Wednesday.

Kelly Turner faces up to 16 years in prison for the 2017 death of her daughter Olivia Gant, who the mother said suffered from multiple illnesses, including a seizure disorder and a tumor, according to an indictment against her.

But authorities say Turner fabricated her daughter’s supposed ailments and illnesses for years, convincing medical professionals to perform surgeries and treat illnesses she never had.

Olivia’s cause of death, intestinal failure, was still later determined to be false.

The baby girl’s body was exhumed in 2018 as part of an investigation into the mother, and a medical examination revealed no signs of intestinal failure.

Authorities have not released an updated cause of death.

But, according to the indictment, Turner was successful in getting the doctor to stop feeding her daughter after she was admitted to Colorado Children’s Hospital.

Olivia was fed through a feeding tube in hospital where doctors said she had nutritional deficiencies.

Turner also pleaded guilty to felony theft and felony charitable fraud.

The mother defrauded the Medicaid system of more than $538,000, according to the indictment, as well as charitable foundations like Make-A-Wish.

Kelly Turner abused her daughter Olivia Gant by forcing the 7-year-old to undergo unnecessary surgeries and defrauding Medicare.
Denver Police Department/The Denver Post via AP

She gained sympathy for Olivia through television reports, a GoFundMe site, and blogs that detailed Olivia’s various health issues without medical evidence.

Turner’s behavior, according to psychiatrists, aligns with Munchausen syndrome by proxy, a psychological disorder in which a parent or caregiver lies or creates an illness their dependent is suffering from to get attention.

With post wires

About Michael Bill

Check Also

Small-molecule drug could offer breakthrough treatment for cancerous brain tumors

A new type of small-molecule drug, the first to target circadian clock proteins as a …